Research Management Group (RMG)

Global Health Funding Opportunities


This webpage contains miscellaneous global health funding opportunities.


What's new

  • HHMI, Gates Foundation, Wellcome Trust, Calouste Gulbenkian Foundation-2017 International Research Scholars Program (June 30) more >>
  • Bill and Melinda Gates Foundation-Global Grand Challenges-Round 16 recipients announced more >>
  • NIH funding opportunities **updated** (now arranged by topic and/or regionmore >>
  • NIH-Zika-virus funding opportunities updates & reminders
    more >>
  • The Pew Latin American Fellows Program in the Biomedical Sciences (Oct. 3) more >>


    Other Resources:
  • Global Oncology (GO! )- Global Cancer Project Map more >>
  • Consortium of University for Global Health-2016 Conference videos are now available (link to CUGH webpage)


Special announcement


Bill and Melinda Gates Foundation
Howard Hughes Medical Institute
Wellcome Trust
Calouste Gulbenkian Foundation
2017 International Research Scholars Program

Amount of funding: $650,000 over 5 years
Purpose:
This program seeks to encourage promising scientists early in their career who have the strong potential to make groundbreaking contributions in science in a manner that will further the partners’ respective charitable missions and result in a greater impact on key global health challenges. In addition to the financial support the scholars will receive, they will be integrated into a community that fosters their interactions with each other and with other scientists supported by the partner organizations.
Eligibility:
Applicants must meet the following requirements:
-must hold a doctoral or medical degree and completed postdoctoral research training
-have received training at the doctoral, medical, or postdoctoral level in the U.S. or the U.K. for at least 1-year
-have started their first independent research position on or after April 1, 2009
-have been the first or senior author on at least two peer-reviewed, English-language, original research publications
-conduct biomedical resarch on basic biological and disease mechanisms; the research may also be in the areas of chemistry, physics, computer science, or engineering that are directly related to biology or medicine.
-Hold a full-time position as an independent scientist at a research-oriented university, medical school, or nonprofit institution in any country OTHER THAN: The G-7 Countries (Canada, France, Germany, Italy, Japan, United Kingdom, & United States) AND OTHER THAN sanctioned countries or territories (which include Iran, North Korea, Sudan, Syria, and the Crimea region of Ukraine)
Timeline:
Institutional representative (RPM/RMG or OSR) deadline: June 23, 2016
Deadline: June 30, 2016
Guidelines:
https://www.hhmi.org/news/philanthropies-announce-program-develop-scientific-talent-worldwide
FYI: 2012 recipients:
http://www.hhmi.org/news/hhmis-international-early-career-scientists



 

Bill and Melinda Gates Foundation Funding Opportunities

Bill and Melinda Gates Foundation
Grand Challenges Round 17

The deadline for this program has passed.

http://gcgh.grandchallenges.org/grant-opportunities?f[0]=field_initiative%3A37073




Bill and Melinda Gates Foundation
Global Grand Challenges-Round 16 recipients announced

Recipients: webpage >>
May 2016: Dr. Paul Bollyky, Assistant Professor, Med/Infectious Diseases-Stanford is one of the $100K recipients for Round 16
Description of his project- webpage>>

 


Bill and Melinda Gates Foundation
Message from the CEO more >>


Bill and Melinda Gates Foundation:
Open Concept Memo Global Health Grants

Note-this program has been discontinued.

 

 


Global Oncology (GO!)



Global Oncology (GO!)
Dr. Ami Bhatt, Stanford University School of Medicine, is the co-founder and co-president of GO!
http://globalonc.org/

 

Global Oncology (GO!)
The Global Cancer Project Map (GCPM)
Purpose: The Global Cancer Project Map, released on March 25, 2015, is a web-based platform that catalogs international cancer research, cancer care, and cancer outreach programs. The platform aligns cancer care efforts of governmental agencies, non-profit organizations, academic institutions and industry partners.
The creation of the Global Cancer Project Map and its potential to facilitate cancer control and research programs in resource-poor settings have been a result of an alliance between Global Oncology, Inc. and the National Cancer Institute’s Center for Global Health. Thanks to the database expertise and content standards provided by the National Cancer Institute, a component of the National Institutes of Health and an agency of the U.S. Department of Health and Human Services, the Global Cancer Project Map provides resources to partners across the world to address the challenges of cancer and reduce cancer-related deaths.
Objectives: The GCPM’s primary objectives are to:
- Facilitate the breaking down of silos and building of collaboration
-Accelerate progress, ensure a balanced investment of resources, and align global cancer care and cancer efforts
-Provide resources to view and better understand international efforts in cancer research and control
Special thanks to the Center for Global Health National Cancer Institute, U.S.A.
Website:
http://globalonc.org/Projects/global-cancer-project-map/

 


http://globalonc.org/Projects/global-cancer-project-map/

 


NIH Global Health Funding Opportunities

  • Cancer related programs more >>
  • Career Development Program-U.S. researchers more >>
  • Career Development Program for investigators in LMIC countries more >>
  • Ethics Education and Curriculum more >>
  • H3Africa: Notice of Intent to publish RFPs this summer: "Human Heredity and Health in Africa (H3Africa): Ethical, Legal, and Societal Issues (ELSI)" RFPs this summer more >>
  • HIV
  • Infectious diseases: Modeling of Infectious Disease Agent Study Research Projects more >>
  • India-U.S. Collaborative Vision Research Program more >>
  • Indo-U.S. Vaccine Action Program more >>
  • Limited submission program(s) for foreign institutions more >>
  • Mental health: Research Partnerships for Scaling Up Mental Health Interventions in Low-and Middle-Income Countries (U19) more >>
  • Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21) (PAR-16-292) *reissued*
  • Neuroscience: NIH Global Brain and Nervous System Disorders Research Across the Lifespan more >>
  • NHLBI T4 Translation Research Capacity Building Initiative in Low Income Countries (TREIN) more >>
  • South Africa: Revision Applications for U.S-South Africa Program for Collaborative Biomedical Research more >>
  • Turkey-U.S. Collaborative Program for Affordable Medical Technologies more >>
  • Zika Virus more >>
  • Institutional representatives (RPM/RMG or OSR) and Internal Proposal Deadline policy more >>

 

 


Cancer related programs

 

NIH NCI Planning for Regional Centers of Research Excellence in Non-communicable Diseases in Low and Middle Income Countries (P20) (RFA-CA-15-007)
National Cancer Institute
Activities in this FOA will be implemented through
collaborative partnerships between investigators from institutions in high-income countries (HICs) or upper- middle-income countries (UMICs) and investigators, research administrators, and other stakeholders from LMICs. The planning efforts must demonstrate an understanding of the region's research capabilities and a commitment to enhance these capabilities with a focus on basic, translational, clinical, and population science research for Non-Communicable Diseases (NCDs). Research activities undertaken through this initiative should demonstrate that the collaborators can work together to answer NCD questions that are relevant, timely, and important to the concerned region.
Eligibility: Stanford faculty with PI eligibility and CE faculty (with an approved CE faculty PI waiver)
Remaining application Receipt Date(s): August 23, 2016
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-15-007.html



NIH bioengineering/biomedical engineering funding opportunties
Including NCI RFPs more >>




Career development award for U.S. researchers:

NIH FIC International Research Scientist Development Award (IRSDA) (K01) (PAR-15-291)
John E. Fogarty International Center
National Cancer Institute (update)
NIH will contribute up to $ 75,000 per year toward the salary of the career award recipient for 3 to 5 years.
NIH will contribute $30,000 per year for 3 to 5 years toward the research development costs of the award recipient, which must be justified and consistent with the stage of development of the candidate and the proportion of time to be spent in research or career development activities.
Stanford Eligibility clarification**:
--Advanced postdoctoral
U.S. research scientists, and recently-appointed U.S. junior faculty
-- assistant professors
with PI eligiblity and CE assistant professors (with an approved CE faculty PI waiver) (at least two years beyond conferral of doctoral degree)
--Stanford Instructors, and Academic Staff Researchers are also eligible per the NIH program official.
Purpose:
The purpose of the International Research Scientist Development Award (IRSDA) is to provide support and protected time (three to five years) to advanced postdoctoral U.S. research scientists, Instructors**, and Academic Staff Researchers** and recently-appointed U.S. junior faculty (at least two years beyond conferral of doctoral degree) for an intensive, mentored research career development experience in a low- or middle-income country (LMIC) leading to an independently funded research career focused on global health. FIC invites applications from early-career investigators from any health related discipline who propose career development activities and a research project that is relevant to the health priorities of the LMIC.
See the guidelines for additional eligibility criteria
Institutional representative (RPM/RMG or OSR) deadline: Feb. 27, 2017; Feb. 28, 2018
Remaining Application Receipt/Submission Date(s): March 2, 2017; March 7, 2018 by 5:00 PM local time of applicant organization.
http://grants.nih.gov/grants/guide/pa-files/PAR-15-291.html

 

NIH BD2K Mentored Career Development Award in Biomedical Big Data Science for Clinicians and Doctorally Prepared Scientists (K01)" RFA-ES-16-002
Mulitiple participating institutes (including Fogarty International Center)
Eligibility: investigators in U.S. institutions only
By the time of award, the individual must be a citizen or a non-citizen national of the United States or have been lawfully admitted for permanent residence (i.e., possess a currently valid Permanent Resident Card USCIS Form I-551, or other legal verification of such status
The award is intended for research-oriented investigators at any level of experience, from the postdoctorates to mid-career and senior level facultyl, who have shown clear evidence of productivity and research excellence in the field of their training, and who would like to expand their research capability with a mentored career devlopment experience, with the goal of making significant contributions to develop technology, tools and methods for research in Big Data Science.
Deadline:   August 1, 2016
http://grants.nih.gov/grants/guide/rfa-files/RFA-ES-16-002.html


NIH K Career Development Award resource webpage:
http://med.stanford.edu/rmg/funding/nih_kawards.html


Funding Opportunities for postdoctoral and medical fellows:
Foundations/associations, NIH, NSF more >>

 

Career Development Award for investigators in institutions in LMIC countries


NIH Emerging Global Leader Award (K43) (PAR-15-292)

John E. Fogarty International Center
National Cancer Institute (update)
National Human Genome Research Institute
National Institute of Environmental Health Sciences
National Institute of Mental Health
To provide research support and protected time to a research scientist from a low- or middle-income country (LMIC) with a junior faculty position at an LMIC academic or research institution. This intensive, mentored research career development experience is expected to lead to an independently funded research career. This Funding Opportunity Announcement (FOA) invites applications from LMIC scientists from any health related discipline that propose career development activities and a research project that is relevant to the health priorities of their country.
The purpose of the Fogarty Emerging Global Leader Award is to provide research support and protected time to a research scientist from a low- or middle-income country (LMIC) with a junior faculty position at an LMIC academic or research institution. This intensive, mentored research career development experience is expected to lead to an independently funded research career.
Institutional representative (RPM/RMG or OSR) deadline: Dec. 7, 2016; Dec. 7, 2017;
Remaining Application Receipt/Submission Date(s): December 14, 2016; and December 14, 2017
Guidelines:
http://grants.nih.gov/grants/guide/pa-files/PAR-15-292.html

 

 

Ethics Education and Curriculum

NIH FIC NHGRI NIAID International Research Ethics Education and Curriculum Development Award (R25) (PAR-16-081) *reissued*
John E. Fogarty International Center
National Human Genome Research Institute
National Institute of Allergy and Infectious Diseases
To accomplish the stated overarching goal, this FOA will support creative education activities with a primary focus on: Curriculum Development; Courses for Skills Development, including practicum experiences; and Mentoring Activities.
Eligibility : Applications should include collaborations between bioethics experts from LMIC, U.S. (faculty with PI eligiblity) and other high income countries (HIC).
Remaining Application Receipt/Submission Date(s): May 18, 2017; May 17, 2018), by 5:00 PM local time of applicant organization.
http://grants.nih.gov/grants/guide/pa-files/PAR-16-081.html

 

H3Africa


Notice of Intent to Publish RFPs this summer for the Human Heredity and Health in Africa (H3Africa): Ethical, Legal, and Societal Issues (ELSI) (Note-The actual FOAs will be published this summer.)
Research Program (U01) (NOT-RM-16-014)
Collaborative Centers (U54) (NOT-RM-16-015)
Research Grants (U01) (NOT-RM-16-016)
Collaborative Centers (U54) (NOT-RM-16-017)
Administrative Coordinating Center (U24) (NOT-RM-16-018)
Informatics Network (U24) (NOT-RM-16-019)
Global Health Bioinformatics Research Training Program (U2R) (NOT-RM-16-020)
NIH Roadmap Initiatives
National Human Genome Research Institute
The Common Fund/Office of Strategic Coordination

 

HIV

 

Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43) (PAR-16-279) *reissued*
FIC, NCI, NIAAA, NIDA, NIMH
An application should focus the proposed training program to strengthen research capacity in a defined HIV scientific area at a specific LMIC institution or at LMIC sites in an established HIV research network. LMIC institutions now have the options to apply to the D43 FOA or to the D71 (planning grant) FOA. Another change is that the beneficiary of the training supported through this FOA is expanded to include LMIC sites in an established HIV research network.
Application Receipt/Submission Date(s): August 25, 2016; August 23, 2017; August 23, 2018)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-279.html

Planning Grant for Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D71) (PAR-16-281) *reissued*
FIC, NCI, NIAAA, NIDA, NIMH
These applications must propose a plan to develop a research training program and the subsequent application that will be submitted in response to the companion D43 FOA (PAR-16-279). The planned research training program should strengthen research capacity in a defined high priority HIV scientific area (NOT-OD-15-137) at a specific LMIC institution or at LMIC sites in an established HIV research network.
Application Receipt/Submission Date(s): August 25, 2016; August 23, 2017; August 23, 2018
http://grants.nih.gov/grants/guide/pa-files/PAR-16-281.html

Infrastructure Development Training Programs for Critical HIV Research at Low-and Middle-Income Country Institutions (G11) (PAR-16-280) *reissued*
FIC, NCI, NIAAA, NIDA, NIMH
This FOA encourages collaborative applications from U.S. and LMIC institutions to support training to achieve technical, administration and financial management expertise required for one of the six research infrastructure functions considered critical to a successful high quality research environment: 1) Research administration and management; 2) Research integrity oversight; 3) Ethical review of research for the protection of human subjects; 4) Laboratory animal welfare oversight; 5) Health sciences library and information services; and 6) Information and communications technology systems (ICT) for research
Application Receipt/Submission Date(s): August 25, 2016; August 23, 2017; August 23, 2018
http://grants.nih.gov/grants/guide/pa-files/PAR-16-280.html

 

 


India-U.S. Vision Research program



India-U.S. Collaborative Vision Research Program (R01) (PAR-15-320)

National Eye Institute
Encourages applications from United States (U.S.)-based institutions with an Indian institution partner to establish bilateral collaborations that will advance science and technology important to understanding, preventing, and treating blinding eye diseases, visual disorders, and their complications. This program is designed to develop collaborations between scientists and institutions in the United States and India to conduct high quality vision research of mutual interest and benefit to both countries while developing the basis for future institutional and individual scientific collaborations.
Eligibility: Stanford faculty with PI eligibility
Remaining deadlnes application Receipt/Submission Date(s): November 9, 2016; November 9, 2017
Guidelines:
http://grants.nih.gov/grants/guide/pa-files/PAR-15-320.html

 


Indo-U.S. Vaccine Action Program

Indo-U.S. Vaccine Action Program (VAP) Small Research Grant Program (R03) (PA-16-163)
National Institute of Allergy and Infectious Diseases
This initiative offers to support VAP research activities and encourages research leading to the development of new and improved vaccines and related products, and technologies to combat infectious diseases of importance in India, the U.S., the South Asian region and globally.
NOTE: While applicants must provide evidence of ongoing or proposed scientific collaborations specific to the research proposed in the grant application, this initiative will not require joint application, review and funding of applications by the U.S. and India as was required in previous VAP-supported research projects. Standard NIH application and review procedures will be followed. NIAID will fund the grants supported by this FOA.
Standard R03 small grant deadlines: Feb. 16, June 16, Oct. 16
Standard AIDS-related deadlines: May 7, Sept. 7, Jan. 7
Expiration date: May 8, 2019
http://grants.nih.gov/grants/guide/pa-files/PA-16-163.html


Infectious diseases


Modeling of Infectious Disease Agent Study Research Projects (R01) (PA-16-107)
National Institute of General Medical Sciences
Standard R01 deadlines: Feb. 5, June 5, Oct. 5
Standard AIDS-related deadlines: May 7, Sept. 7, Jan. 7
Expiration date: May 8, 2019
http://grants.nih.gov/grants/guide/pa-files/PA-16-107.html

 


Limited submission program(s) for foreign institutions

NIH NIAID Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11) PAR-15-131
Limited: Only ONE application is permitted from each LMIC institution:
Eligibility: Eligible organizations must be in an LMIC (Low to Middle Income Country), as defined by The World Bank http://data.worldbank.org/about/country-and-lending-groups, and includes research institutions in LMICs. Eligible applicant foreign institutions in LMICs are limited to those receiving less than $500,000 per year in any one year in total NIH grant and cooperative agreement support. In order to assure that the US host institutions have appropriate expertise in the management and administration of NIH grants, the applicants’ US host institutions are limited to US institutions that, at the time of submission, have received more than $5 million per year in total NIH research grant or cooperative agreement support within the last 10 years. The PD/PI should be a senior institutional staff member with responsibility for grants administration (e.g. grants administrator, business official, or scientist with institutional grants management responsibilities). A doctorate degree is not required to be the PD/PI.
Letter of intent due 30 days prior to the application deadline
Remaining Full Deadlines: July 15, 2016, July 14, 2017
http://grants.nih.gov/grants/guide/pa-files/PAR-15-131.html

 

 

Mental health

 

Research Partnerships for Scaling Up Mental Health Interventions in Low-and Middle-Income Countries (U19) (PAR-16-174)
National Institute of Mental Health
The objective of this FOA is to stimulate and support research partnerships that will (a) conduct implementation research aligned with LMIC efforts to scale up sustainable, evidence-based mental health interventions and thereby close the mental health treatment gap, and (b) build and sustain capacity in LMICs to conduct implementation research and use science-based methods and information to develop mental health policies and programs.
Each awarded project is to conduct implementation research and research capacity-building activities in LMICs in any one of the following geographical regions: East Asia and the Pacific; Europe and Central Asia; Latin America and the Caribbean; Middle East and North Africa; South Asia; Sub-Saharan Africa
To meet the goal of building and sustaining capacity to conduct implementation research and using science-based methods and information to develop mental health policies and programs, each application must involve two or more LMICs in capacity-building endeavors - to include the lead LMIC (where the implementation research is to be carried out) and one or more additional countries in the region. NIMH encourages the use of existing LMIC systems, platforms, or data bases, where possible, for building LMIC capacity to conduct implementation research and to foster evidence-based mental health policy and program development. .
Applications should not: Propose research to be conducted primarily in and/or by United States or other high income country institutions.
Propose research on the scale up of mental health services exclusively for HIV+ populations.
Application Receipt/Submission Date(s): July 15, 2016, by 5:00 PM local time of applicant organization.
http://grants.nih.gov/grants/guide/pa-files/PAR-16-174.html

 

 

Mobile Health


Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21) (PAR-16-292) *reissued*
FIC, NCI, NIBIB, NIDCD, NIMH, OBSSR
The overall goal of the FOA is to contribute to the evidence base for the use of mobile technology to improve clinical outcomes and public health while building research capacity in LMICs and establishing research networks in this area.
Applicants are required to propose partnerships between at least one U.S. institution and one LMIC institution and the proposed research plan should strengthen the mHealth research capabilities at the LMIC institution.
Application Receipt/Submission Date(s): August 31, 2016; August 31, 2017; August 31, 2018
http://grants.nih.gov/grants/guide/pa-files/PAR-16-292.html

 

 


Neuroscience

 

NIH Global Brain and Nervous System Disorders Research Across the Lifespan (R01) PAR 14-332
FIC, NEI, NIA, NICHD, NIDCD, NIDA, NIEHS, NIMH, NINDS, ODS

Eligibility: Stanford faculty with PI eligibility and CE faculty (with an approved CE faculty PI waiver)
Remaining deadline: January 5, 2017
http://grants.nih.gov/grants/guide/pa-files/PAR-14-332.html

NIH Global Brain and Nervous System Disorders Research Across the Lifespan (R21) PAR-14-331
FIC, NIA, NICHD, NIDCD, NIDA, NIEHS, NIMH, NINDS, ODS
Eligibility: Stanford faculty with PI eligibility and CE faculty (with an approved CE faculty PI waiver)
Remaining deadline: Jan. 5, 2017
http://grants.nih.gov/grants/guide/pa-files/PAR-14-331.html

 

 

NHLBI

NIH NHLBI T4 Translation Research Capacity Building Initiative in Low Income Countries (TREIN) (U24) (RFA-HL-17-003)
National Heart, Lung, and Blood Institute
Up to $138,000 direct costs per year for up to 4 years
Eligibility: Only applications from LIC institutions with collaborations in either/or high income countries and/or other low or middle income countries are encouraged to apply. Applications from high income or middle income countries are not eligbile for the FOA.
To solicit applications that propose to build in-country capacity through the creation of a trans-disciplinary investigative team to guide the conduct of late-stage translation phase 4 research (T4TR) in low income countries (as defined by The World Bank) through skills development programming, needs assessment, and capacity building. Studies will be required to address chronic non-communicable heart, lung, blood and sleep diseases and disorders in low income countries.
Application Receipt Date(s): June 15, 2016
http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-17-003.html



South Africa

Revision Applications for U.S-South Africa Program for Collaborative Biomedical Research (R01) (RFA-AI-16-039)
National Institute of Allergy and Infectious Diseases
National Cancer Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
Eligibility: Revision applications will only be accepted from South African institutions/organizations with active NIH R01 funding (direct award) and from active NIH R01 institutions/organizations funded in response to RFA-AI-14-009.
Application Receipt Date(s): August 2, 2016
Guidelines:
http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-16-039.html

Revision Applications for U.S-South Africa Program for Collaborative Biomedical Research (U01) (RFA-AI-16-040)
National Institute of Allergy and Infectious Diseases
National Cancer Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Eligibility: Revision applications will only be accepted from South African institutions/organizations with active NIH U01 funding (direct award) and from active NIH U01 institutions/organizations funded in response to RFA-AI-14-018.
Application Receipt Date(s): August 2, 2016
http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-16-040.html

 

 

Turkey-U.S. affordable medical technologies


Turkey-US Collaborative Program for Affordable Medical Technologies (R01) (PAR-15-276)

National Cancer Institute
National Institute of Biomedical Imaging and Bioengineering
To fund research partnerships formed between scientists in the U.S. and Turkey to accelerate the development of appropriate affordable diagnostic and therapeutic technologies, which address medical needs in LMIC settings. Appropriate medical technologies are those that are useable, cost effective, sustainable, and effective in meeting a significant clinical need in LMIC resource setting in different world regions.
Eligibility: The colloboration must involve at least one U.S. investigator (Stanford faculty with PI eligibility and CE faculty (with an approved CE Faculty PI waiver) from an eligible U.S. institution and at least one Turkish collaborator from an eligible Turkish instituition (either a non-profit or an academic insitution as determined by the Scientific and Technological Research Council of Turkey TUBITAK).
Standard R01 deadlines: Feb. 5, June 5, Oct. 5
Standard AIDS-related deadlines: May 7, Sept. 7, Jan. 7
Expiration date: Jan. 8, 2018
http://grants.nih.gov/grants/guide/pa-files/PAR-15-276.html

 


Zika Virus

 

NIH Fogarty International Center: Zika Virus Information and Resources
NIH FIC webpage >>
containing links to numerous articles.



Rapid Assessment of Zika Virus (ZIKV) Complications (R21) (PAR-16-106)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Eye Institute
National Heart, Lung, and Blood Institute
National Institute of Allergy and Infectious Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute of Dental and Craniofacial Research
National Institute of Neurological Disorders and Stroke
National Institute of Mental Health (*just added in May 2016*)
Eligibiility: faculty wlith PI eligibility and CE faculty (with an approved CE fauclty PI waiver)
Institutional representative (RPM/RMG or OSR)-please submit your proposals through your RPM/RMG or OSR.
School of Medicine PIs-please contact your RPM as soon as possible of your plans to submit an application.
Application Receipt/Submission Date(s): Applications will be accepted on a rolling basis, beginning on April 20, 2016.
http://grants.nih.gov/grants/guide/pa-files/PAR-16-106.html


**Note: Notice (NOT-NS-16-027) of Clarification of Research Areas for the above FOA:
At the time of publication of this funding opportunity announcement, data was not yet available on the association of ZIKV with Guillain-Barré Syndrome (GBS) and other neurological complications in adults.
Now that such data is emerging, this Notice is intended to amend the list of possible areas of high priority to include:
-Studies of Guillain-Barré Syndrome (GBS), encephalitis or encephalomyelitis associated with ZIKV infection to determine disease course and outcomes, causality, disease mechanisms, effectiveness of current treatments and to develop novel treatments.
-This Notice is also intended to encourage immunologists to apply their expertise to understanding and treating immune mechanisms of ZIKV-associated GBS or other neurological complications.


Immunity to Neonates and Infants (U01) RFA-AI-16-001*
NIAID, NIEHS, ORWH
Deadline: July 29, 2016
Program announcement:
http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-16-001.html
*Note: Notice (NOT-AI-16-055) that PIs can also submit Zika Virus Infections to the above RFA.



NIAID- High Priority Zika Virus Research Areas

Per notice NOT-AI-16-026 NIAID highlights its interest in research on, and product development for, Zika Virus.
See this notice for suggested topic areas.

NIAID suggests PIs can use these RFAs/PAs to pursue the research areas

NIH Small Research Grant Program (Parent R03) (PA-16-162)
Multiple participating institutes
Standard R03 small grant deadlines: Feb. 16, June 16, Oct. 16
Program announcement:
http://grants.nih.gov/grants/guide/pa-files/PA-16-162.html
Table of Parent R03 grant institute contacts:
http://grants.nih.gov/grants/guide/contacts/parent_R03.html

NIH Research Project Grant (Parent R21) PA-16-161
Multiple NIH participating agencies
Standard R21 deadlines: Feb. 16, June 16, Oct. 16
Standard AIDS-related deadlines: May 7, Sept. 7, Jan. 7
Expiration date: Sept. 8, 2019
Program announcement:
http://grants.nih.gov/grants/guide/pa-files/PA-16-161.html
Table of institute contacts for this R21 RFA--you are encouraged to discuss your project with the scientific program officer for the institute that most closely relates to your research.
http://grants.nih.gov/grants/guide/contacts/parent_R21.html

Research Project Grant (Parent R01) PA-16-160
Multiple participating agencies
Eligibility: faculty with PI eligibility and CE faculty (with an approved CE faculty PI waiver)
Standard R01 deadlines: Feb 5, June 5, Oct. 5
Standard AIDS-related deadlines: May 7, Sept. 7, Jan. 7
Expiration date: May 8, 2019
http://grants.nih.gov/grants/guide/pa-files/PA-16-160.html
Institute contacts: You are strongly encouraged to discuss your research project with the NIH scientific program official for the institute which most closely relates to your project. The table of institute contacts and information can be found on this webpage:
http://grants.nih.gov/grants/guide/contacts/parent_R01.html




NHLBI recommends that PIs submit their proposals through these existing funding opportunities:

Topics:
NHLBI recommended PIs submit applications pertaining to research to evaluate the risk of and clinical impact of potential transmission of the Zika virus by transfusion. Per Notice (NOT-HL-16-307) Such research interests include but are not limited to:
Characterization of the prevalence of the virus among blood donors in different geographical regions; Quantitation and dynamics of the evolution of viremia in blood donors; Transmissibility studies in relevant animal models; Dynamics of viremia in recipients post transfusion; Development of Zika screening and confirmatory assays; Transfusion-transmission studies; Evaluations of potential strategies to reduce or prevent Zika transmission by blood transfusion

The NHLBI is recommending PIs talk to their program contacts about submitting proposals through these existing funding opportunities?

Research Project Grant (Parent R01) PA-16-160
Multiple participating agencies (including National Cancer Institute-NCI)
Eligibility: faculty with PI eligibility and CE faculty (with an approved CE faculty PI waiver)
Standard R01 deadlines: Feb 5, June 5, Oct. 5
Standard AIDS-related deadlines: May 7, Sept. 7, Jan. 7
Expiration date: May 8, 2019
http://grants.nih.gov/grants/guide/pa-files/PA-16-160.html
Institute contacts: You are strongly encouraged to discuss your research project with the NIH scientific program official for the institute which most closely relates to your project. The table of institute contacts and information can be found on this webpage:
http://grants.nih.gov/grants/guide/contacts/parent_R01.html




NIH NHLBI Selected Topics in Transfusion Medicine (R01) PAR-13-026

National Heart, Lung and Blood Institute (NHLBI)
Eligibility: faculty wlith PI eligibility and CE faculty (with an approved CE faculty PI waiver)
R01 deadlines: Feb. 5, June 5*, Oct. 5
Expiration date: Jan. 8, 2017
http://grants.nih.gov/grants/guide/pa-files/PAR-13-026.html

*NHLBI program contact: check witih the scientific program contact listed below to discuss your project and this Cycle 2 deadline)


NIH NHLBI Selected Topics in Transfusion Medicine (R21) PAR-13-027
National Heart, Lung and Blood Institute (NHLBI)
Eligibility: faculty wlith PI eligibility and CE faculty (with an approved CE faculty PI waiver)
R21 exploratory/developmental deadlines: Feb. 16, June 16*, Oct. 16
Expiration date: Jan. 8, 2017
http://grants.nih.gov/grants/guide/PA-files/PAR-13-025.html

**NHLBI program contact: check witih the scientific program contact listed below to discuss your project and this Cycle 2 deadline)


PA-15-269, PHS 2015-02 Omnibus Solicitation of the NIH, CDC, FDA, and ACF for Small Business Innovation Research Grant Applications (Parent SBIR)
Small business award mechanism
http://grants.nih.gov/grants/guide/pa-files/PA-15-269.html


PA-15-270, PHS 2015-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42])
Small business award mechanism
https://grants.nih.gov/grants/guide/notice-files/NOT-HL-13-201.html


NHLBI Scientific Program Contacts

Investigators interested in developing applications for Zika virus-related blood supply safety and transfusion research are strongly encouraged to discuss their ideas with the NHLBI contacts listed below:

Division of Blood Diseases and Resources
Simone Glynn, M.D., M.P.H.
Telephone: 301-435-0065
Email: glynnsa@nhlbi.nih.gov

Small Business Coordinator
Jennifer Shieh, Ph.D.
Telephone: 301-496-2149
Email: nhlbi_sbir@mail.nih.gov

 

 

NICHD, NINDS, NIDCR, NIAID- Zika Virus as it relates to the mother-infant dyad and sequelae of infection.

NIH Notice (NOT-HD-16-004) interest in research on Zika virus (ZIKV) as it relates to the mother-infant dyad and sequelae of infection.

Priority Resarch Areas: see below for priority Zika-related research areas >>

Existing funding opportunities to use to submit your proposals:
The NIH notice includes the following possible funding opportunities that can be used.

Eligibility: Stanford faculty with PI eligibility (UTL, MCL and NTL-Research) and CE faculty (with an approved CE faculty PI waiver >>)

Research Project Grant (Parent R01) PA-16-160
Multiple participating agencies (including National Cancer Institute-NCI)
Eligibility: faculty with PI eligibility and CE faculty (with an approved CE faculty PI waiver)
Standard R01 deadlines: Feb 5, June 5, Oct. 5
Standard AIDS-related deadlines: May 7, Sept. 7, Jan. 7
Expiration date: May 8, 2019
http://grants.nih.gov/grants/guide/pa-files/PA-16-160.html
Institute contacts: You are strongly encouraged to discuss your research project with the NIH scientific program official for the institute which most closely relates to your project. The table of institute contacts and information can be found on this webpage:
http://grants.nih.gov/grants/guide/contacts/parent_R01.html


NIH Research Project Grant (Parent R21) PA-16-161
Multiple NIH participating agencies
Eligibility: faculty wlith PI eligibility and CE faculty (with an approved CE faculty PI waiver)
Standard R21 deadlines:   Feb. 16, June 16, Oct. 16
Standard AIDS-related deadlines: May 7, Sept. 7, Jan. 7
Expiration date: Sept. 8, 2019
Program announcement:
http://grants.nih.gov/grants/guide/pa-files/PA-16-161.html
Table of institute contacts for this R21 RFA--you are encouraged to discuss your project with the scientific program officer for the institute that most closely relates to your research.
http://grants.nih.gov/grants/guide/contacts/parent_R21.html



NIH NICHD Advancing Understanding, prevention, and management of Infections Transmitted from Women to their Infants (R21) PAR-16-031

Standard R21 deadlines: Feb. 16, June 16, Oct. 16
AIDS-related deadlines: May 7, Sept. 7, Jan. 7
Expiration date: Sept. 8, 2019
http://grants.nih.gov/grants/guide/pa-files/PA-16-031.html


NIH NICHD Advancing Understanding, prevention, and management of Infections Transmitted from Women to their Infants (R01) PAR-16-032

Standard R01 deadlines: Feb. 5, June 5, Oct. 5
AIDS-related deadlines: May 7, Sept. 7, Jan. 7
Expiration date: Sept. 8, 2019
http://grants.nih.gov/grants/guide/pa-files/PA-16-032.html


NIH Parallel Funding Initiative for Collaborative Research Between Investigators in the USA and in the State of Sao Paulo, Brazil (NOT-TW-16-001)

The National Institute of Health (NIH) and the São Paulo Research Foundation (FAPESP), Brazil, have signed a memorandum of understanding (MOU) to encourage collaborative international research between investigators in the US and in the State of São Paulo.
Per this notice PIs must submit applications using the above investigator-initiated R01 parent grant.
Notice webpage:
http://grants.nih.gov/grants/guide/notice-files/NOT-TW-16-001.html
*Per the notice PIs must submit applications using the above investigator-initiated R01 grant.


NIH NICHD and NIDDK Natural History of Disorders Identifiable by Screening of Newborns (R01) PAR-16-061

Standard R01 deadlines: Feb. 5, June 5, Oct. 5
AIDS-related deadlines: May 7, Sept. 7, Jan. 7
Expiration date: May 8, 2019
http://grants.nih.gov/grants/guide/pa-files/PAR-16-061.html


NIH Global Brain and Nervous System Disorders Research Across the Lifespan (R21) PAR-14-331

FIC, NIA, NICHD, NIDCD, NIDA, NIEHS, NIMH, NINDS, ODS
Remaining deadline: Jan. 5, 2017
http://grants.nih.gov/grants/guide/pa-files/PAR-14-331.html


NIH Global Brain and Nervous System Disorders Research Across the Lifespan (R01) PAR-14-332

FIC, NIA, NICHD, NIDCD, NIDA, NIEHS, NIMH, NINDS, ODS
Remaining deadline: Jan. 5, 2017
http://grants.nih.gov/grants/guide/pa-files/PAR-14-332.html


NIH NIDCR Immune System Plasticity in the Pathogenesis and Treatment of Complex Dental, Oral, and Craniofacial Diseases (R01) PAR-15-192

Standard R01 deadlines: Feb. 5, June 5, Oct. 5
AIDS-related deadlines: May 7, Sept. 7, Jan. 7
Expiration date: Sept. 8, 2018
http://grants.nih.gov/grants/guide/pa-files/PAR-15-192.html


NIH NIDCR Immune System Plasticity in the Pathogenesis and Treatment of Complex Dental, Oral, and Craniofacial Diseases (R21) PAR-15-193

Standard R21 deadlines: Feb. 16, June 16, Oct. 16
AIDS-related deadlines: May 7, Sept. 7, Jan. 7
Expiration date: Sept. 8, 2018
http://grants.nih.gov/grants/guide/pa-files/PAR-15-193.html



NICHD, NINDS, NIDCR, NIAID Areas of High Priority for Zika virus research for the above RFPs:

    • Demonstrate causative role of infection in pregnancy with Zika virus (ZIKV) in the etiology of fetal microcephaly
    • Basic research to understand the ZIKV infection pathogenesis and transmission to the fetus, whether in-utero, postpartum, or breastfeeding
    • Population-based studies to characterize the epidemiology of ZIKV infection in the mother-infant dyad
    • Clinical studies to improve the understanding of the mechanisms and risks of maternal to child transmission of ZIKV
    • Determine the timeline for when and how women transmit ZIKV to the fetus
    • Strategies to prevent transmission of ZIKV to the fetus after infection in the mother
    • Studies to determine the optimal screening for and management of ZIKV infection in pregnant women and in exposed fetuses
    • Studies to understand the mechanisms by which ZIKV affects the developing nervous system and other organ systems
    • Research to develop lab-based or point-of-care diagnosis for ZIKV using saliva as a biofluid
    • Studies to characterize the outcome of viral infection on craniofacial skeletal and dental phenotype with or without microcephaly
    • Studies to understand pregnancy outcomes in women infected with ZIKV
    • Studies to identify sequelae in infants infected with ZIKV as well as potential sequelae in exposed but uninfected infants
    • Strategies to identify neurologic and other manifestations in infants with and without microcephaly such as developmental delays and other neurologic or physical disorders
    • Studies to assess and characterize the natural history and long-term neurodevelopmental consequences of ZIKV infection in children
    • Strategies to identify effective treatments for exposed infants with and without microcephaly as they develop into childhood.
    • Such strategies must take into account cultural acceptance and resources
    • Investigations of mediating and moderating factors affecting variability in neurodevelopmental, behavioral, and socio-emotional impact of ZIKV exposure on infants prenatally and postnatally
    • Develop novel, simple, feasible and cost-effective testing methods and/or strategies for infection screening during pregnancy
    • Develop novel, simple, rapid, feasible and cost effective testing methods and/or strategies for infection screening in the infant
    • Research to develop lab-based or point-of-care diagnosis for ZIKV using saliva as a biofluid
    • Develop culturally sensitive strategies to increase knowledge about the relative efficacy of contraceptive methods, and use that knowledge to plan for pregnancy
    • Strategies to integrate the discussion of risk of ZIKV infection into contraceptive counseling and pre-pregnancy and prenatal care at medical facilities in ZIKV endemic areas
    • Determine long-term implications of ZIKV infection in non-pregnant women and men including impact on fertility and subsequent pregnancy
    • Studies to ascertain if ZIKV is present in reproductive fluids such as semen, cervical mucus, vaginal secretions and/or follicular fluid; persistence of ZIKV in these fluids; and the mechanisms by which ZIKV enters the reproductive tract
    • Studies on effects of ZIKV on in vitro fertilization
    • Studies on whether ZIKV can be transmitted by direct sexual contact or artificial reproductive technology procedures
    • Once causality is demonstrated, studies on vaccine development in pregnant women and children
    • Once causality is demonstrated, development of methods to explain risk of ZIKV infection and risk of harm to the fetus to pregnant women and women who are planning to become pregnant

 




Foundation and Association funding opportunities

 

 

Pew Latin American Fellows Program in the Biomedical Sciences
Purpose: The Pew Latin American Fellows Program in the Biomedical Sciences provides support for young scientists from Latin America to receive postdoctoral training in the United States. The program gives these individuals an opportunity to further their scientific knowledge by promoting exchange and collaboration between investigators in the United States and Latin America resulting in advances in research in Latin America.
Eligibility: for the 2017 application process:
-applicants must have been awarded a Ph.D. and or M.D. degree by February 2017 but not for more than five years prior to July 1, 2017.
-preference will be given to applicants who received their undergraduate and graduate degrees from institutions in Latin America.
-applicants may have obtained their undergraduate or graduate degrees from a school outside of Latin America but preferably not in the United States.
-applicants may not have had previous postdoctoral training in the United States in excess of 18 months prior to July 1, 2017
-applicants will not be considered if they have completed graduate work with a proposed sponsor.
-applicants are required to submit a written statement of intent to return to Latin America.
Timeline:
Institutional representative (RMG Fellowship Office) internal deadline: Sept. 26, 2016**
Sponsor's Deadline: Oct. 3, 2016
Program overview (with links to 2015 fellows)
http://www.pewtrusts.org/en/projects/pew-latin-american-fellows
Program details (eligibility)
http://www.pewtrusts.org/en/projects/pew-latin-american-fellows/program-details
How to apply:
It provides instructions on contacting the Pew program official re: how to access their online application
http://www.pewtrusts.org/en/projects/pew-latin-american-fellows/to-apply
*Institutional representative: submit your completed PDRF form and application materials to the RMG Fellowship Office per the proposal checklist/guidelines on this webpage >>.

Funding Opportunities for postdoctoral and medical fellows:
Foundations/associations, NIH, NSF more >>

 

 

Emergency Medicine Foundation
International Emergency Medicine Outcomes and Efficacy Research Grant

To promote projects that seek to demonstrate improved patient outcomes in Emergency Departments in low-to middle-income countries (LMICs).Seed grant for up to $10,000 for one year (2 to be awarded)
Eligibility; faculty with PI eligibility and CE faculty (with an approved CE faculty PI waiver)
PIs must have a primary appointment in Emergency Medicine
Institutional representative (RPM/RMG): Feb.
Deadline: Feb.
https://www.conferenceabstracts.com/cfp2/login.asp?EventKey=GKJONVNC


 

Global Fund for Women
The Global Fund for Women invests in women's groups that advance the human rights of women and girls. We strengthen women-led groups based outside the United States by providing grants ranging from $5,000 to $30,000 per year for operating and project expenses. First-time grant awards generally range from $5,000 to $13,000 per year.
To be eligible for General Support Grants or Travel Grants, a group may only have one proposal of any type under consideration at a given time.
Types of grants: General support grants: Innovation, Strengthening, and Impact Grants (see guidelines for details)
Eligibility: The women's organization must be based in a country outside the United States. We do not fund US based organizations. Its primary focus is advancing women's equality and human rights, with these goals clearly reflected in its activities. It is a group of women working together. We do not accept requests from individuals. It is governed, directed, and led by women. Women must fill all or most of the leadership roles.
Included in the lists of thematic areas is: Advancing Health and Sexual & Reproductive Rights
Deadline: TBA
http://www.globalfundforwomen.org/apply-for-a-grant

 

Conquer Cancer Foundation
International Innovation Grant

$20,000 for 1 yr
Eligibility: paid directly to a nonprofit organization or governmental agency in a low-income or middle-income country. The grant may be used by the organization only for the approved, budgeted costs of the research project.
Each grant will have a Principal Investigator who is an ASCO-American Society of Clinical Oncology member, is affiliated with the Grantee Organization, and is a resident of the low-income or middle-income country.
Letter of intent (required) deadline: July
Full application deadline: Oct.
https://www.conquercancerfoundation.org/grants-awards

 

 


Miscellaneous Resources

 

Stanford Center for Innovation in Global Health
http://globalhealth.stanford.edu/

Society for Neuroscience
Global Funding Sources resource webpage >>


Stanford Woods Institute for the Environment
Water, Health and Development Program

http://water.stanford.edu/





Center for Disease Control (CDC)


To search for CDC funding opportunities, go to the Grants.gov Advanced Search webpage:
http://www.grants.gov/web/grants/search-grants.html
Search by keyword-enter: CDC
Eligibility: Stanford faculty with PI eligibility with UTL, MCL, NTL-Research appointments
and CE Faculty with an approved CE Faculty PI waiver>>



U.S. Agency for International Development

 

Grantsgov Search Tool
Click on the "browse agencies" tab on this webpage and then select
"Agency for International Development" to view their current announcements:
http://www.grants.gov/web/grants/home.html



Stanford resources

 

Institutional Representatives
*Medicine: RPM Assignments by department webpage >>
You are encouraged to alert your RPM 3-4 weeks prior to any sponsor’s deadline so that your budget can be completed no later than 10 days prior to the sponsor’s deadline. Per the above policy, the internal proposal/institutional representative deadline is the complete by date** and not the “let’s get started date”. [**5 working days prior to the sponsor’s deadline your fully approved and completed PDRF form and application materials must be provided to your RPM/RMG or OSR.]
*Other schools: Download the Pre-award OSR department assignments on this DoResearch webpage >>


Internal proposal deadline policy, best practices and FAQs for grants, contracts, subcontracts and fellowships:
School of Medicine PIs
SoM internal proposal deadline policy and FAQs: webpage >>.
CE faculty you must submit and receive approval for a CE faculty PI waiver through your RPM prior to submitting a pre-application per these instructions >>
Other schools
Office of Sponsored Research (OSR) internal deadline policy and FAQs: DoResearch webpage >>

Stanford Research Development Office (SRDO), School of Medicine
The SRDO is an additional and optional resource for School of Medicine faculty applying for grants. Its priorities for grants include large center or program project grants, grants on topics aligned with the Dean's initiatives, and junior faculty, i.e., assistant professors, applying for their first major research grants, such as NIH R01 and similar grants. SRDO's services will include identification of funding opportunities, editing of proposals, project management and assembly of large proposals, interfacing with sponsors and university central offices, and promoting collaborations. The contacts are Michael K. Helms, PhD, MBA (mkhelms@stanford.edu, 650-723-4526), Director of SRDO, and Sandra Holden, PhD (srholden@stanford.edu, 650-724-5345), Grant Development Officer.
SRDO website (SUNET ID required for access)
https://srdo.spectrum.stanford.edu/

 

 




 

 



 




Footer Links: